Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

الموضوعات:

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. حسب Denis Mustafov (19137870)

"…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …"

The linearly decreasing convergence factor a. حسب Junhao Wei (6816803)

Side effects of vaccination that affected participants’ children. حسب Sara Saleh (6733619)

الموضوعات:

Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation حسب Xiaoyu Shen (4715430)

الموضوعات:

Contains R code utilized in the analyses. حسب Arttu Autio-Kimura (20454681)

الموضوعات:

Brain regions with significantly decreased activations for the Raven task are shown in blue. حسب Morteza Fattahi (15892028)

Fig 1 - حسب Farshid Maleki (20521649)

الموضوعات:

Fig 8 - حسب Farshid Maleki (20521649)

الموضوعات:

Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. حسب Farshid Maleki (20521649)

الموضوعات:

Fig 4 - حسب Farshid Maleki (20521649)

الموضوعات:

Fig 9 - حسب Farshid Maleki (20521649)

الموضوعات:

Trypan blue dye exclusion assay for cell viability evaluation (% of control). حسب Farshid Maleki (20521649)

الموضوعات:

Fig 7 - حسب Farshid Maleki (20521649)

الموضوعات:

Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). حسب Farshid Maleki (20521649)

الموضوعات:

Fig 10 - حسب Farshid Maleki (20521649)

الموضوعات:

Fig 5 - حسب Farshid Maleki (20521649)

الموضوعات:

Fig 6 - حسب Farshid Maleki (20521649)

الموضوعات:

Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). حسب Farshid Maleki (20521649)

الموضوعات: